- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03456921
Using an End-of-life Conversation Game to Engage Underserved Communities in Advance Care Planning
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The project goal explores how best to meet the needs of underserved communities to improve engagement in the advance care planning (ACP) process, which is defined as a complex and ongoing process that involves discussions with loved ones and/or clinicians, and/or may involve completion of an advance directive document. This national project involves two components: 1) a community outreach program, Community Game Days; and 2) a research project. The community outreach component seeks to provide an effective, evidence based ACP intervention to 50 underserved communities (defined as those with poor access to healthcare systems due to economic, cultural or linguistic barriers). Of these, 15 African American communities across the United States will be selected for participation in the research aspect of the project which seeks to assess the program's impact on and to learn about the unique needs of African American populations with regard to ACP. A highly integrated, collaborative approach will be used, bringing together a national organization concerned about end-of-life care (the Hospice Foundation of America (HFA) and a university-based academic research team (led by Dr. Lauren Van Scoy at Penn State Milton S. Hershey Medical Center through her research program, Project Talk).
The project teams will organize and support a 14-month long community outreach project that will bring an end-of-life conversation game, "Hello," to 50 communities across the United States. The game has been found to stimulate substantive, enjoyable and meaningful end-of-life discussions among participants. Further, over 70% of participants who played the game went on to perform additional ACP behaviors.2-4 That body of research is limited, however, by a primarily Caucasian or South Asian Indian demographic. It is well established that African Americans have historically low rates of ACP completion when compared to Caucasians and that they often receive overly aggressive and unwanted care at the end-of-life.5,6 Thus, learning how best to engage the African American population in ACP activities is critical. Thus, this research project aims to determine whether and to what extent this priming activity yields similar results in African American communities. The research team will conduct mixed methods research on the impact of the game on the performance of subsequent ACP behavior as well as explore the broad needs of African American communities with regards to ACP.
Fifteen of the 50 qualified locations who can demonstrate through a screening process the ability to attract a majority African American audience will be selected to participate in the research aspect of the project which will involve: 1) pre-game questionnaires to assess population characteristics and readiness to engage in ACP, 2) post- game questionnaires to assess satisfaction, realism about the conversation game and readiness to engage in ACP, 3) post-game focus groups to further explore opinions about the game, the value of priming activities, and the broad needs of the community for encouraging ACP, and 4) 3 month follow-up phone interviews to assess ACP behaviors that have been performed and perceived impact of the priming activity. Participants from the additional 35 sites can opt-in to participate in a 3 months follow-up phone call. As the trial progressed, the time-frame for follow-up phone interviews was extended to 3 - 9 months.
Upon completion of this project, this collaboration is expected to have reached up to 1000 African American individuals and 1,500 other underserved individuals and provided them with an enjoyable and rich experience that facilitates communication about end-of-life issues. The research data is expected to provide a significant contribution to the field by yielding information about the needs of 15 African American communities as well as to yield data related to the impact of the priming activity (the game) on ACP behaviors in this traditionally underserved group.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Pennsylvania
-
Hershey, Pennsylvania, États-Unis, 17011
- Penn State Hershey College of Medicine
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Are over the age of 18
- Attend a community Game Day event hosted as part of the Hospice Foundation of America community outreach "Hello Project"
Exclusion Criteria:
- Do not speak English
- Have significant difficulties with hearing or speaking difficulties by self-report
- Do not provide informed consent
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Participants au jeu
Tous les participants participeront au jeu de conversation sur la fin de vie appelé « Bonjour », qui consiste à répondre à des questions ouvertes sur la prise de décision médicale et les problèmes de fin de vie.
|
To play 'Hello', players are provided 32 open-ended questions in a prearranged order and an equal number of game chips.
A player reads aloud the first question.
Players then individually write down their answers, and take turns sharing answers with the group (players can opt to pass).
Players control how long they share, what they share, and when they are ready to proceed to the next question.
During the conversation, players may choose to acknowledge others for a particularly thoughtful, poignant, or even funny comment by giving them a chip.
A simple pre-game coin flip determines whether the player with the most chips 'wins' the game ('heads'), or the player with the least amount of chips wins the game ('tails').
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Rate of ACP Behaviors
Délai: 9 months post intervention
|
This phone questionnaire assesses whether participants went on to perform various behaviors related to advance care planning.
|
9 months post intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in ACP Engagement Survey scores
Délai: Baseline (Day 0); immediately post-intervention (Day 0); 3-9 months post intervention
|
This validated questionnaire measure assesses engagement in various ACP behaviors and/or readiness to perform ACP behaviors.
Items are scored on a 5 point Likert scale (1-5, with 5 indicating highest readiness to perform ACP).
Items are averaged for a final score ranging 1-5.
|
Baseline (Day 0); immediately post-intervention (Day 0); 3-9 months post intervention
|
|
Conversation satisfaction questionnaire
Délai: Immediately post-intervention (Day 0)
|
Measures participants' satisfaction with the conversation.
There are 5 items in the measure, each item is scored on a 1-7 scale with 1 being lowest conversation satisfaction.
The items are averaged for the final score ranging 1-7 with 7 indicating the highest conversation satisfaction.
|
Immediately post-intervention (Day 0)
|
|
ACP Values/Beliefs Questionnaire
Délai: immediately post-intervention (Day 0)
|
Measure participants' attitudes about ACP.
This a 8-item questionnaire.
Scores are calculated by summative responses and the total score ranges from 7-49 with 7 being the least amount of skepticism (a better outcome).
|
immediately post-intervention (Day 0)
|
|
Conversation Realism Questionnaire
Délai: immediately post-intervention (Day 0)
|
The Conversation Realism survey is an 8-item questionnaire that measures how realistic players felt the game conversation was.
Each question is measured with a 7- point Likert scale, with "1" being the least realistic and "7" being the most realistic (better outcome) conversation.
|
immediately post-intervention (Day 0)
|
|
Net Promoter Score
Délai: immediately post-intervention (0)
|
The Net Promoter Score is a widely single-question (How likely are you to recommend Hello to friends and family?) used to measure participants' game experience on a 10-point scale.
It is measured in two ways: (1) raw score is measured on a 10-point scale with 0 being "not likely at all" to 10 (better outcome) being "extremely likely" (2) calculated score = 10-point scale is broken down as follows: detractor score (0-6); passive score (7-8); promoter score (9-10).
Passive scores are ignored.
The calculated score is: (total number of promoters) - (total number of detractors) / (total number of responses) = score ranging from - 100 to +100 with +100 being the best (better outcome).
|
immediately post-intervention (0)
|
|
Hello Game Assessment - Qualitative focus group interview
Délai: immediately post-intervention (Day 0)
|
Group discussions held to collect feedback and opinions about playing the conversation game.
Data collected is qualitative.
|
immediately post-intervention (Day 0)
|
|
ACP Needs Assessment - Qualitative focus group interview
Délai: immediately post-intervention (Day 0)
|
Qualitative focus groups will explore the needs of diverse African American populations with regards to ACP and end-of-life planning
|
immediately post-intervention (Day 0)
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Lauren J Van Scoy, Penn State College of Medicine
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- Study00009009
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Maladie en phase terminale
-
Instituto Nacional de Ciencias Medicas y Nutricion...ComplétéHémodialyse | Maladie rénale chronique au stade terminalMexique
-
University of FloridaM.D. Anderson Cancer Center; National Cancer Institute (NCI); Northwestern University et autres collaborateursComplété
-
Fondazione IRCCS Policlinico San Matteo di PaviaComplétéSyndrome de vision par ordinateur | Travailleurs du terminal d'affichage vidéo
-
Texas Biotechnology CorporationComplétéInsuffisance rénale chronique | Maladie rénale, stade terminalÉtats-Unis
-
University of AlbertaCanadian Institutes of Health Research (CIHR); Alberta Health services; Cambian... et autres collaborateursComplétéMaladie rénale, phase terminaleCanada
-
Yvan Beaussant, MD, MSciHeffter Research Institute; Usona Institute; Oppenheimer Family Psychosocial... et autres collaborateursComplétéMaladie en phase terminale | Psychothérapie | Psilocybine | Hospice | Démoralisation | Problème/état lié au cancer | Cancer en phase terminale | Cancer terminalÉtats-Unis
-
Odense University HospitalRecrutementMaladie de Crohn de l'iléon terminalDanemark
-
PfizerComplétéInsuffisance rénale chronique | Insuffisance rénale aiguë | Maladie rénale, stade terminalÉtats-Unis
-
Nicholas CarlsonPas encore de recrutementTransplantation rénale | Dialyse | Maladie du rein | Insuffisance rénale au stade terminal (ESKD) | Maladie rénale chronique (stades 4 et 5)
-
Qidni Labs Inc.RecrutementMaladie rénale, phase terminaleCanada
Essais cliniques sur End-of-life conversation game called "Hello"
-
Memorial Sloan Kettering Cancer CenterRésiliéLes familles ou proches parents des patients traités au MSKCC pour des carcinomes épidermoïdes non cutanés du | Voies aérodigestives supérieuresÉtats-Unis